drugset / Trial / NCT00339196
5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
Non-randomizedSingle-groupOpen-labelTreatment
Summary
MULTICENTERS. Uncontrolled and open phase II study. Evaluation of the effectiveness of a treatment associating 5 Azacytidine,Valproic acid ,Retinoic Acid at subjects-reached of syndromes myelodysplasia and acute MYELOID leukaemia Hematological response at 6 months Uncontrolled prospective cohort.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | — | — |
| Subject | Isotretinoin | Other / unclassified | — | — |
| Subject | Valproic Acid | Small molecule | — | — |